You are here: Industry Insights > Com-Cov

News List

‘Mix and match’ COVID-19 vaccine study yields promising results pharmatimes
June 30, 2021
A study evaluating a mix and match approach to COVID-19 vaccinations has found that using a different jab for the first and second doses gives good protection against the virus.
Oxford Immunotec’s COVID-19 test to be used in ‘mix and match’ UK vaccine trial pharmatimes
April 28, 2021
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 test kit is set to be used for T cell testing in the UK Com-Cov trial, which is evaluating different combinations of approved COVID-19 vaccines.
UK trial evaluating ‘mix and match’ COVID-19 vaccine regimens expanded pharmatimes
April 15, 2021
A UK trial evaluating the safety of mixing different COVID-19 vaccines is set to be expanded to include Moderna and Novavax’s respective jabs.
UK trial will evaluate safety of mixing different COVID-19 vaccines pharmatimes
February 04, 2021
A new clinical study, based in the UK, will investigate alternating COVID-19 vaccine doses with the aim of examining whether different vaccines can safely be used for two-dose regimens.